8 research outputs found
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers.
Cytotoxic T lymphocyte (CTL)-based cancer immunotherapies have shown great promise for inducing clinical regressions by targeting tumor-associated antigens (TAA). To expand the TAA landscape of pancreatic ductal adenocarcinoma (PDAC), we performed tandem mass spectrometry analysis of HLA class I-bound peptides from 35 PDAC patient tumors. This identified a shared HLA-A*0101 restricted peptide derived from co-transcriptional activator Vestigial-like 1 (VGLL1) as a putative TAA demonstrating overexpression in multiple tumor types and low or absent expression in essential normal tissues. Here we show that VGLL1-specific CTLs expanded from the blood of a PDAC patient could recognize and kill in an antigen-specific manner a majority of HLA-A*0101 allogeneic tumor cell lines derived not only from PDAC, but also bladder, ovarian, gastric, lung, and basal-like breast cancers. Gene expression profiling reveals VGLL1 as a member of a unique group of cancer-placenta antigens (CPA) that may constitute immunotherapeutic targets for patients with multiple cancer types
Hypervirulent group A Streptococcus emergence in an acaspular background is associated with marked remodeling of the bacterial cell surface
Inactivating mutations in the control of virulence two-component regulatory system (covRS) often account for the hypervirulent phenotype in severe, invasive group A streptococcal (GAS) infections. As CovR represses production of the anti-phagocytic hyaluronic acid capsule, high level capsule production is generally considered critical to the hypervirulent phenotype induced by CovRS inactivation. There have recently been large outbreaks of GAS strains lacking capsule, but there are currently no data on the virulence of covRS-mutated, acapsular strains in vivo. We investigated the impact of CovRS inactivation in acapsular serotype M4 strains using a wild-type (M4-SC-1) and a naturally-occurring CovS-inactivated strain (M4-LC-1) that contains an 11bp covS insertion. M4-LC-1 was significantly more virulent in a mouse bacteremia model but caused smaller lesions in a subcutaneous mouse model. Over 10% of the genome showed significantly different transcript levels in M4-LC-1 vs. M4-SC-1 strain. Notably, the Mga regulon and multiple cell surface protein-encoding genes were strongly upregulated–a finding not observed for CovS-inactivated, encapsulated M1 or M3 GAS strains. Consistent with the transcriptomic data, transmission electron microscopy revealed markedly altered cell surface morphology of M4-LC-1 compared to M4-SC-1. Insertional inactivation of covS in M4-SC-1 recapitulated the transcriptome and cell surface morphology. Analysis of the cell surface following CovS-inactivation revealed that the upregulated proteins were part of the Mga regulon. Inactivation of mga in M4-LC-1 reduced transcript levels of multiple cell surface proteins and reversed the cell surface alterations consistent with the effect of CovS inactivation on cell surface composition being mediated by Mga. CovRS-inactivating mutations were detected in 20% of current invasive serotype M4 strains in the United States. Thus, we discovered that hypervirulent M4 GAS strains with covRS mutations can arise in an acapsular background and that such hypervirulence is associated with profound alteration of the cell surface
Hypervirulent group A Streptococcus emergence in an acaspular background is associated with marked remodeling of the bacterial cell surface.
Inactivating mutations in the control of virulence two-component regulatory system (covRS) often account for the hypervirulent phenotype in severe, invasive group A streptococcal (GAS) infections. As CovR represses production of the anti-phagocytic hyaluronic acid capsule, high level capsule production is generally considered critical to the hypervirulent phenotype induced by CovRS inactivation. There have recently been large outbreaks of GAS strains lacking capsule, but there are currently no data on the virulence of covRS-mutated, acapsular strains in vivo. We investigated the impact of CovRS inactivation in acapsular serotype M4 strains using a wild-type (M4-SC-1) and a naturally-occurring CovS-inactivated strain (M4-LC-1) that contains an 11bp covS insertion. M4-LC-1 was significantly more virulent in a mouse bacteremia model but caused smaller lesions in a subcutaneous mouse model. Over 10% of the genome showed significantly different transcript levels in M4-LC-1 vs. M4-SC-1 strain. Notably, the Mga regulon and multiple cell surface protein-encoding genes were strongly upregulated-a finding not observed for CovS-inactivated, encapsulated M1 or M3 GAS strains. Consistent with the transcriptomic data, transmission electron microscopy revealed markedly altered cell surface morphology of M4-LC-1 compared to M4-SC-1. Insertional inactivation of covS in M4-SC-1 recapitulated the transcriptome and cell surface morphology. Analysis of the cell surface following CovS-inactivation revealed that the upregulated proteins were part of the Mga regulon. Inactivation of mga in M4-LC-1 reduced transcript levels of multiple cell surface proteins and reversed the cell surface alterations consistent with the effect of CovS inactivation on cell surface composition being mediated by Mga. CovRS-inactivating mutations were detected in 20% of current invasive serotype M4 strains in the United States. Thus, we discovered that hypervirulent M4 GAS strains with covRS mutations can arise in an acapsular background and that such hypervirulence is associated with profound alteration of the cell surface
Proteomics Profiling of Exosomes from Primary Mouse Osteoblasts under Proliferation versus Mineralization Conditions and Characterization of Their Uptake into Prostate Cancer Cells
Osteoblasts
communicate both with normal cells in the bone marrow
and with tumor cells that metastasized to bone. Here we show that
osteoblasts release exosomes, we termed osteosomes, which may be a
novel mechanism by which osteoblasts communicate with cells in their
environment. We have isolated exosomes from undifferentiated/proliferating
(D0 osteosomes) and differentiated/mineralizing (D24 osteosomes) primary
mouse calvarial osteoblasts. The D0 and D24 osteosomes were found
to be vesicles of 130–140 nm by dynamic light scattering analysis.
Proteomics profiling using tandem mass spectrometry (LC–MS/MS)
identified 206 proteins in D0 osteosomes and 336 in D24 osteosomes.
The proteins in osteosomes are mainly derived from the cytoplasm (∼47%)
and plasma membrane (∼31%). About 69% of proteins in osteosomes
are also found in Vesiclepedia, and these canonical exosomal proteins
include tetraspanins and Rab family proteins. We found that there
are differences in both protein content and levels in exosomes isolated
from undifferentiated and differentiated osteoblasts. Among the proteins
that are unique to osteosomes, 169 proteins are present in both D0
and D24 osteosomes, 37 are unique to D0, and 167 are unique to D24.
Among those 169 proteins present in both D0 and D24 osteosomes, 10
proteins are likely present at higher levels in D24 than D0 osteosomes
based on emPAI ratios of >5. These results suggest that osteosomes
released from different cellular state of osteoblasts may mediate
distinct functions. Using live-cell imaging, we measured the uptake
of PKH26-labeled osteosomes into C4-2B4 and PC3-mm2 prostate cancer
cells. In addition, we showed that cadherin-11, a cell adhesion molecule,
plays a role in the uptake of osteosomes into PC3-mm2 cells as osteosome
uptake was delayed by neutralizing antibody against cadherin-11. Together,
our studies suggest that osteosomes could have a unique role in the
bone microenvironment under both physiological and pathological conditions
Proteomics Profiling of Exosomes from Primary Mouse Osteoblasts under Proliferation versus Mineralization Conditions and Characterization of Their Uptake into Prostate Cancer Cells
Osteoblasts
communicate both with normal cells in the bone marrow
and with tumor cells that metastasized to bone. Here we show that
osteoblasts release exosomes, we termed osteosomes, which may be a
novel mechanism by which osteoblasts communicate with cells in their
environment. We have isolated exosomes from undifferentiated/proliferating
(D0 osteosomes) and differentiated/mineralizing (D24 osteosomes) primary
mouse calvarial osteoblasts. The D0 and D24 osteosomes were found
to be vesicles of 130–140 nm by dynamic light scattering analysis.
Proteomics profiling using tandem mass spectrometry (LC–MS/MS)
identified 206 proteins in D0 osteosomes and 336 in D24 osteosomes.
The proteins in osteosomes are mainly derived from the cytoplasm (∼47%)
and plasma membrane (∼31%). About 69% of proteins in osteosomes
are also found in Vesiclepedia, and these canonical exosomal proteins
include tetraspanins and Rab family proteins. We found that there
are differences in both protein content and levels in exosomes isolated
from undifferentiated and differentiated osteoblasts. Among the proteins
that are unique to osteosomes, 169 proteins are present in both D0
and D24 osteosomes, 37 are unique to D0, and 167 are unique to D24.
Among those 169 proteins present in both D0 and D24 osteosomes, 10
proteins are likely present at higher levels in D24 than D0 osteosomes
based on emPAI ratios of >5. These results suggest that osteosomes
released from different cellular state of osteoblasts may mediate
distinct functions. Using live-cell imaging, we measured the uptake
of PKH26-labeled osteosomes into C4-2B4 and PC3-mm2 prostate cancer
cells. In addition, we showed that cadherin-11, a cell adhesion molecule,
plays a role in the uptake of osteosomes into PC3-mm2 cells as osteosome
uptake was delayed by neutralizing antibody against cadherin-11. Together,
our studies suggest that osteosomes could have a unique role in the
bone microenvironment under both physiological and pathological conditions
Recommended from our members
Genome-wide identification and differential analysis of translational initiation
Translation is principally regulated at the initiation stage. The development of the translation initiation (TI) sequencing (TI-seq) technique has enabled the global mapping of TIs and revealed unanticipated complex translational landscapes in metazoans. Despite the wide adoption of TI-seq, there is no computational tool currently available for analyzing TI-seq data. To fill this gap, we develop a comprehensive toolkit named Ribo-TISH, which allows for detecting and quantitatively comparing TIs across conditions from TI-seq data. Ribo-TISH can also predict novel open reading frames (ORFs) from regular ribosome profiling (rRibo-seq) data and outperform several established methods in both computational efficiency and prediction accuracy. Applied to published TI-seq/rRibo-seq data sets, Ribo-TISH uncovers a novel signature of elevated mitochondrial translation during amino-acid deprivation and predicts novel ORFs in 5′UTRs, long noncoding RNAs, and introns. These successful applications demonstrate the power of Ribo-TISH in extracting biological insights from TI-seq/rRibo-seq data